Elekta (OTCMKTS:EKTAY) Issues Earnings Results

Elekta (OTCMKTS:EKTAY) posted its earnings results on Thursday. The company reported $0.07 earnings per share (EPS) for the quarter, Zacks reports. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%.

Elekta Stock Performance

EKTAY stock opened at $5.50 on Friday. The business’s fifty day moving average is $5.19 and its 200-day moving average is $5.70. The company has a market cap of $2.03 billion, a P/E ratio of -34.38 and a beta of 1.01. The company has a quick ratio of 0.68, a current ratio of 0.87 and a debt-to-equity ratio of 0.47. Elekta has a twelve month low of $4.35 and a twelve month high of $6.93.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 28th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce”.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.